-(1)-1.jpg){kind=logo}
UMB will host the third International Conference of the Society for Interdisciplinary Placebo Studies (SIPS), “Harnessing Placebo Mechanisms for Optimal Pain Management and Treatment of Alcohol and Other Drug Use Disorders," virtually, May 26-28. The cost to attend is $15 for UMB employees.
Expert faculty from UMB's Schools of Medicine, Nursing, and Pharmacy have collaborated with SIPS to design an interdisciplinary, international scientific conference to advance the science of placebo research and mind-body mechanisms and to apply this knowledge to alcohol use and pain disorders.
The conference will provide a collaborative platform to present and share innovative research findings and theoretical ideas on placebo research to an international audience of researchers; promote training and education of trainees, academic junior researchers, health care professionals, agencies, stakeholders, and the public; and advocate for the participation of minorities and women while expanding U.S. research in the global network of placebo research.
The program will include:
- Seven plenary sessions
- Three special sessions on COVID-19, placebo methodology, and virtual reality
- Over 20 workshops
- Peer-reviewed short oral presentations
- Peer-reviewed poster sessions
- Networking forums
Continuing education (CE) credit will be available for physicians, nurses, and pharmacists.
Presentations to include Plenary lecture 6: Why psychotherapy is an open-label placebo and open-label placebo is psychotherapy by Jens Gaab, PhD, full professor, University of Basel, Switzerland, with an introduction by Jason Noel, PhD, associate professor, University of Maryland School of Pharmacy.
Gaab is interested in the practice and research of psychotherapy and placebo and how to understand and use their mutual relationship in an ethically feasible way.